ECM
CRL icon

ETrade Capital Management’s Charles River Laboratories CRL Stock Holding History

ETrade Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$981K Sell
4,330
-308
-7% -$63.9K 0.02% 380
2020
Q2 		$809K Sell
4,638
-215
-4% -$34.3K 0.02% 418
2020
Q1 		$612K Sell
4,853
-534
-10% -$80.1K 0.02% 416
2019
Q4 		$823K Sell
5,387
-206
-4% -$28.5K 0.02% 409
2019
Q3 		$740K Buy
5,593
+426
+8% +$57.1K 0.02% 431
2019
Q2 		$733K Sell
5,167
-20
-0.4% -$2.71K 0.02% 430
2019
Q1 		$754K Sell
5,187
-383
-7% -$50.3K 0.02% 407
2018
Q4 		$630K Buy
5,570
+8
+0.1% +$1K 0.02% 426
2018
Q3 		$748K Buy
5,562
+393
+8% +$48.5K 0.02% 455
2018
Q2 		$580K Buy
5,169
+422
+9% +$45.6K 0.02% 495
2018
Q1 		$507K Buy
4,747
+2,758
+139% +$297K 0.02% 508
2017
Q4 		$218K Buy
+1,989
New +$216K 0.01% 695

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

ETrade Capital Management's CRL Position: Q3 2020 in Review

ETrade Capital Management reduced its Charles River Laboratories (CRL) stake by 6.6% in Q3 2020, selling an estimated $63.9K and leaving 4,330 shares worth $981K. The position accounts for 0.02% of the portfolio, ranked #380.

ETrade Capital Management first reported a position in CRL in Q4 2017 and has held it in 12 quarters since. 492 funds tracked by Wall St. Rank hold CRL as of Q3 2020.

  • ETrade Capital Management held 4,330 shares of Charles River Laboratories worth $981K as of Q3 2020.
  • ETrade Capital Management sold 308 Charles River Laboratories shares in Q3 2020, an estimated $63.9K.
  • Charles River Laboratories made up 0.02% of ETrade Capital Management's portfolio in Q3 2020, its #380 holding.
  • ETrade Capital Management first reported a position in Charles River Laboratories in Q4 2017 and has held it in 12 quarters since.
  • 492 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2020.

Based on ETrade Capital Management's 13F filing for Q3 2020, filed 13 Nov 2020.